You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CAR-T HIV therapy

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

People Living With HIV Treated With CD19-directed CAR T Cell

Active, not recruiting
  • Leukemia
  • +9 more
    • Philadelphia, Pennsylvania
      Pennsylvania Hospital
    Mar 29, 2023

    Hiv Trial in Philadelphia (CD4 CAR+CCR5 ZFN T-cells)

    Active, not recruiting
    • Hiv
    • CD4 CAR+CCR5 ZFN T-cells
    • Philadelphia, Pennsylvania
      University of Pennsylvania
    Jan 6, 2022

    HIV/AIDS Trial in Guangzhou (CAR-T cells)

    Recruiting
    • HIV/AIDS
    • CAR-T cells
    • Guangzhou, Guangdong, China
      Guangzhou 8th People's Hospital
    Jul 19, 2021

    HIV-1 Trial in Beijing (CAR-T cells)

    Unknown status
    • HIV-1
    • CAR-T cells
    • Beijing, China
      302 Hospital
    Apr 25, 2021

    HIV/AIDS Trial in Guangzhou (Chidamide with CAR-T or TCR-T cell therapy)

    Completed
    • HIV/AIDS
    • Chidamide with CAR-T or TCR-T cell therapy
    • Guangzhou, Guangdong, China
      Guangzhou 8th People's Hospital
    Jul 19, 2021

    AIDS-Related Diffuse Large B-cell Lymphoma, AIDS-Related Non-Hodgkin Lymphoma, HIV Infection Trial (Axicabtagene Ciloleucel,

    Not yet recruiting
    • AIDS-Related Diffuse Large B-cell Lymphoma
    • +14 more
    • Axicabtagene Ciloleucel
    • +2 more
    • (no location specified)
    Feb 15, 2022

    Relapse/Refractory Multiple Myeloma Trial in Hangzhou (DeepTag-GPRC5D Targeted CAR T-cells)

    Recruiting
    • Relapse/Refractory Multiple Myeloma
    • DeepTag-GPRC5D Targeted CAR T-cells
    • Hangzhou, Zhejiang, China
      The first affiliated hospital of medical college of zhejiang uni
    Oct 10, 2023

    HIV Trial in Sacramento, San Francisco (drug, biological, other)

    Recruiting
    • HIV Infections
    • Sacramento, California
    • +1 more
    May 17, 2022

    Gastric Cancer, Colon Cancer, Pancreas Cancer Trial in Nanchang (CEA CAR-T cells)

    Recruiting
    • Gastric Cancer
    • +6 more
    • CEA CAR-T cells
    • Nanchang, Jiangxi, China
      The First Affiliated Hospital of Nanchang University
    Aug 23, 2023

    Lymphoma Trial in Seattle (biological, other, procedure)

    Not yet recruiting
    • Lymphoma
    • Immune Globulin Infusion (Human), 10% Solution
    • +5 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Jul 21, 2023

    B-cell Acute Lymphoblastic Leukemia, B-cell Lymphoma, Diffuse Large B Cell Lymphoma Trial in Beijing (CD19/CD22-bispecific CAR-T

    Recruiting
    • B-cell Acute Lymphoblastic Leukemia
    • +2 more
    • CD19/CD22-bispecific CAR-T cells
    • Beijing, Beijing, China
      Liang Wang
    Oct 7, 2023

    Hematologic Malignancy, CAR-T Cell Therapy Trial in Boston (Educational Video Tool)

    Active, not recruiting
    • Hematologic Malignancy
    • CAR-T Cell Therapy
    • Educational Video Tool
    • Boston, Massachusetts
      Massachusetts General Hospital
    Jan 24, 2023

    Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia, in Relapse Trial in Xuzhou (anti Tim-3/CD123 CAR-T cell therapy)

    Recruiting
    • Acute Myeloid Leukemia Refractory
    • Acute Myeloid Leukemia, in Relapse
    • anti Tim-3/CD123 CAR-T cell therapy
    • Xuzhou, Jiangsu, China
      Kailin Xu
    Nov 4, 2023

    Neuroendocrine Tumor (NET), Colorectal Cancer (CRC) Trial (CHM-2101 CAR-T cells)

    Not yet recruiting
    • Neuroendocrine Tumor (NET)
    • Colorectal Cancer (CRC)
    • CHM-2101 CAR-T cells
    • (no location specified)
    Sep 20, 2023

    Chronic Myelomonocytic Leukemia Trial in Indianapolis (CD4CAR)

    Not yet recruiting
    • Chronic Myelomonocytic Leukemia
    • CD4CAR
    • Indianapolis, Indiana
      Indiana University Melvin and Bren Simon Comprehensive Cancer Ce
    Oct 2, 2023

    CAR-T Cell Induced Cardiac Dysfunction: A Prospective Study

    Not yet recruiting
    • Lymphoma
    • Chimeric Antigen Receptor
    • (no location specified)
    Oct 24, 2023

    Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IVB Prostate Cancer AJCC v8 Trial in Duarte

    Not yet recruiting
    • Castration-Resistant Prostate Carcinoma
    • +2 more
    • Autologous Anti-PSCA-CAR-4-1BB/TCRzeta-CD19t-expressing T-lymphocytes
    • +7 more
    • Duarte, California
      City of Hope Medical Center
    Apr 5, 2023

    Non Hodgkin's Lymphoma Trial in Beijing (TRAC and Power3 Genes Knock-out Allogeneic CD19-targeting CAR-T cell (ATHENA CAR-T),

    Not yet recruiting
    • Non Hodgkin's Lymphoma
    • TRAC and Power3 Genes Knock-out Allogeneic CD19-targeting CAR-T cell (ATHENA CAR-T)
    • +2 more
    • Beijing, China
    • +2 more
    Aug 23, 2023

    Multiple Myeloma, New Diagnosis Tumor Trial in Hangzhou (BCMA CAR-T cells)

    Recruiting
    • Multiple Myeloma
    • New Diagnosis Tumor
    • BCMA CAR-T cells
    • Hangzhou, Zhejiang, China
      The First Affiliated Hospital, College of Medicine, Zhejiang Uni
    Jan 31, 2023

    Recurrent DLBCL, Refractory DLBCL Trial in Duarte (procedure, biological, radiation)

    Not yet recruiting
    • Recurrent Diffuse Large B-Cell Lymphoma
    • Refractory Diffuse Large B-Cell Lymphoma
    • Biospecimen Collection
    • +6 more
    • Duarte, California
      City of Hope Medical Center
    Mar 24, 2023

    Acute Lymphoblastic Leukemia, Lymphoma, Multiple Myeloma Trial in Taiyuan (CAR-T Autologous T cell injection)

    Recruiting
    • Acute Lymphoblastic Leukemia
    • +2 more
    • CAR-T Autologous T cell injection
    • Taiyuan, Shanxi, China
      Shanxi Bethune Hospital
    Dec 2, 2022

    SLE (Systemic Lupus), Sjogren's Syndrome, Systemic Scleroderma Trial in Taiyuan (CD19 targeted CAR-T cells)

    Recruiting
    • SLE (Systemic Lupus)
    • +4 more
    • CD19 targeted CAR-T cells
    • Taiyuan, Shanxi, China
      Shanxi Bethune Hospital
    Sep 25, 2023

    Relapsed/Refractory Multiple Myeloma Trial in Philadelphia (Cevostamab)

    Not yet recruiting
    • Relapsed/Refractory Multiple Myeloma
    • Philadelphia, Pennsylvania
      Hospital of the University of Pennsylvania
    Apr 7, 2023

    Pancreas Cancer, CAR-T Cell Therapy, Mesothelin Trial in Guangzhou (CAR-T cells)

    Recruiting
    • Pancreas Cancer
    • +3 more
    • CAR-T cells
    • Guangzhou, Guangdong, China
      The Second Affiliated Hospital of Guangzhou Medical University
    Mar 10, 2023

    B Acute Lymphoblastic Leukemia, Ph-Negative ALL, High Risk Acute Lymphoblastic Leukemia Trial (Azacitidine Injection,

    Not yet recruiting
    • B Acute Lymphoblastic Leukemia
    • +2 more
    • Azacitidine Injection
    • +2 more
    • (no location specified)
    Oct 15, 2023